Categories
Health

Is Your Vaccine Card Selfie a Reward for Scammers? Perhaps

So you finally got a Covid-19 vaccine. It’s easy to take a photo of your vaccination card with your name and date of birth and the vaccine you had and post it on social media.

However, some experts warn that the information in the festive photo could expose you to identity theft or fraud.

“Unfortunately, your card has your full name and birthday and information about where you got your vaccine from,” the Better Business Bureau said last week. “If your social media privacy settings are not set high, you may be sharing valuable information that anyone can use.”

On Friday, the Federal Trade Commission followed suit: “You post a photo of your vaccination card on social media. Please – don’t do that! “it bluntly warned.” You could invite identity theft. “

Fraudsters can sometimes find out most of the digits of your Social Security number by knowing your date and place of birth. You can open new accounts on your behalf, claim your tax refund for yourself, and get involved in other identity thefts, said Maneesha Mithal, assistant director of the Federal Trade Commission’s privacy and identity protection division.

“Identity theft is like a puzzle made up of personal information,” said Ms. Mithal. “You don’t want to give identity thieves the parts they need to complete the picture. One of these pieces is your date of birth. “

But even if experts warn against giving your card away, chances are the information you are giving up has already been made available in other ways if you recorded your birthday elsewhere online – which most people likely have.

Avivah Litan, a senior analyst at research firm Gartner, said many Americans are vulnerable to multiple data breaches.

“Basically, the criminals already have pretty much every last name, first name and date of birth,” said Ms. Litan. “There have been so many hacks in the last 10 years. If you’re just looking for my name and birthday, you have it. “

Scammers and identity thieves often gradually collect information and clean up social media posts to create a file on a person’s life, including education, employment, and vacation spots. Publishing a date of birth will give you one of your most important personal tidbits.

While a name and date of birth aren’t all an identity thief would need in most cases to steal your identity, it makes it easier to reveal those details.

“Scammers are looking for personal identification information they can get from you – any kind of information to create a profile,” said Curtis W. Dukes, executive vice president of the Center for Internet Security.

A scammer could take advantage of fear of vaccine shortages or a slow distribution process by disguising himself as a government official claiming to need a credit card number to reserve a different dose or booster, Dukes said.

In such a “charged” atmosphere of bottlenecks, people could “fall for it and give up their credit cards or other information,” he said.

Ms. Litan said, “At least it will give bad actors a go-ahead to know who has been vaccinated. So you can use it for fraud purposes, to socially construct me and pay them for a booster shot that I will never get, or for valid commercial purposes that bypass normal US regulatory structures. “

Luscious teenagers post pictures of their driver’s licenses or study permits. Vacationers publish photos of their trips.

The vaccination cards are now another way to “share these milestones in our lives,” said Nita A. Farahany, professor of law and philosophy at Duke University School of Law.

However, she said one concern is that if vaccination status acts as a commodity that gives people access to workplaces, restaurants or events, the cards could be forged or replicated.

Someone who has not yet been vaccinated or does not wish to be vaccinated might “be tempted to forge a copy of these photos,” she said. “Or why wouldn’t a corporate scammer use the photos to create fakes to be sold to whoever they want?”

The Better Business Bureau in its warning cited newspaper reports in the UK that counterfeit vaccination cards were bought on eBay for about $ 6.

When asked about the reports, eBay said in a statement sent via email that it blocked and removed items that made false health claims.

A published vaccination card could also be the springboard for sophisticated social engineering or phishing ideas. Such programs were common during the pandemic.

Stacey Wood, a professor of psychology at Scripps College who has counseled older adults who are victims of fraud, cited what is known as grandparent fraud, in which a person posing as a law enforcement officer contacted an older adult and pretended to give them details about their grandchildren and to say they were in trouble and needed financial help.

“The typical consumer wouldn’t believe that scammers curated information about my life and used it to target me,” she said. “There’s so much going on in my practice right now and it’s just going to be a new thing.”

Cassie Christensen, a consultant at SecZetta who works with organizations to manage identity risk, said people who had their vaccination card issued could open themselves to a scammer posing as an officer trying to verify their identity to get them across inform medical concerns example, suspected new side effects.

The scam could include requests for more information to help them gain access to someone’s accounts, such as a mother’s maiden name or an address.

“You can also go to LinkedIn and find out where you work,” she said. “You can call these organizations and do a legitimate password reset.”

The pandemic and its fears would have created the perfect environment for it.

“It’s all very emotional stuff,” she said. “This is what hackers and phishers are looking for.”

With the distribution of vaccines unevenly, the maps have become a boastful point. Some use it on their dating profiles. Others are just excited to post good news after such a bad year.

“Some post it to say, ‘Look, I got it,” said Duke’s Dr. Farahany.

But what if there was another way of saying that? The Centers for Disease Control and Prevention believe it is. As part of his campaign to build confidence in the vaccines, sticker templates were created and many states, including Wisconsin, Georgia, Texas, Louisiana, New York, and Maryland, are distributing versions of them.

Public health officials are betting on the widespread use of stickers to impact people who may be afraid, indifferent to, or simply against vaccines. The stickers could contribute to so-called “social cascades” of behavior, similar to the way the “I voted” stickers promote voting, experts say.

“It helps encourage similar behavior in other people who may be watching,” said Dr. Tara Kirk Sell, a senior scientist at the Johns Hopkins Center for Health Security. “It’s really about telling others, ‘This is completely normal and that’s what people do.'”

The same behavior occurs when masks are used frequently, making more people feel less out of place wearing one. “We call this ‘social proof,'” said Dr. Wood. “Like, ‘I’ve done my patriotic duty, I’ve done my civic duty.'”

Stickers also don’t reveal personal information, another reason officials promote their use.

In Georgia, Attorney General Chris Carr this week urged people to show vaccination stickers and said he could “not stop them enough from posting their vaccination cards on social media” due to the risk of identity theft.

Also, “the stickers are really cool,” the FTC said on Friday.

Categories
Health

Chamath Palihapitiya-backed Clover Well being will get discover of SEC investigation

Chamath Palihapitiya

Olivia Michael | CNBC

Chamath Palihapitiya-sponsored Clover Health Investments announced Friday that they have received an investigation from the Securities and Exchange Commission and that they intend to cooperate.

However, Clover backed out of a critical report by the short seller Hindenburg Research, saying some of the claims in the report were “totally false”.

On Thursday, Hindenburg released a damning report calling Clover Health a “broken business”. The insurance company’s stocks fell more than 12%, the largest daily percentage decline in four months. Clover’s shares rose more than 3.5% on the Friday leading up to trading after the company released its response. Hindenburg, which has posted short selling in the past, said Thursday it had no position in Clover.

Hindenburg also said that Clover has been investigated by the Justice Department and that the investigation has not been disclosed to investors. In his response to the Hindenburg report, Clover said he had received inquiries from the DOJ, but didn’t believe the inquiries were material to his investors. The company characterized the DOJ inquiries as standard practice because Clover works with the Medicare system.

Clover said it decided not to disclose the DOJ’s inquiries after consulting with its attorneys. The company didn’t say what the DOJ’s inquiries were about. On the SEC side, Clover said he received the agency’s letter Thursday after the Hindenburg report was released. The company said it was unaware of any investigation outside of the SEC’s letter it received Thursday.

The DOJ on Thursday declined to comment on any possible investigation or investigation related to Clover. The SEC declined to comment on Friday.

Clover responded to Hindenburg’s criticism of a separate company, Seek Insurance, that shares investors and governance with Clover. Hindenburg claims that Seek Insurance, a website designed to help people find Medicare plans, does not disclose their relationship with Clover, despite the fact that their website stands out as an unbiased platform for choosing a health plan. Clover said in his response that Seek Insurance is a subsidiary of Clover but is still an independent start-up.

Clover also said that Seek’s website would be updated with more information soon, and released a breakdown of the plans Seek customers are choosing. According to Clover, 13.5% of Seek customers chose a Clover plan, behind CVS / Aetna (17%), Humana (20%) and Cigna (20%).

Finally, Clover responded to Hindenburg’s claims that the company’s software was causing doctors to charge the Medicare system more than necessary, a practice called “upcoding.” According to Hindenburg, Clover’s software encourages up-coding with “irrelevant diagnoses” to “deceive” and charge the Medicare system more. Clover denied these allegations in his response, saying that doctors receive a flat fee for an office visit and that it is up to the doctor to choose the diagnosis.

Hindenburg is known for his short selling research. In particular, a report on electric car company Nikola was released last year, just days after General Motors announced an investment in the company.

Among the allegations made against the company, Hindenburg said Nikola staged a demo video of his electric vehicle, which was not powered by its own but instead rolled down a hill. Nikola denied many of Hindenburg’s claims, but not those about the truck’s demo video. GM eventually gave up its stake in Nikola.

Also of note is Palihapitiya’s commitment to Clover. The VC has built a reputation for supporting several high profile SPAC deals, including Clover and Virgin Galactic. However, Hindenburg’s report raised questions about whether or not Palihapitiya knew about the DOJ’s investigation into Clover, and whether this should have been disclosed when the company went public through the SPAC deal.

You can read all of Clover’s in-depth point-by-point answers on Hindenburg here.

–Reuters contributed to this report.

Categories
Health

Frank Shankwitz, a Founding father of Make-a-Want, Is Useless at 77

Frank Shankwitz, an Arizona Highway Patrol official who co-founded the Make-a-Wish Foundation and served as its first president after helping a terminally ill boy realize his dream of becoming a motorcycle cop, died on January 24 in his home in Prescott, Arizona. He was 77 years old.

His wife, Kitty Shankwitz, said the cause was esophageal cancer.

Mr. Shankwitz was on patrol in April 1980 when one of his superiors radioed him to return to Phoenix Headquarters. The department had found out about a boy named Chris Greicius, who wanted to become a motorcycle officer as an adult, as did Ponch and Jon, the main characters on his favorite TV show “CHiPs”. He also had terminal leukemia.

The department had decided to grant Chris’s request, if only for a few days. A police helicopter took him from the hospital where he was being treated to the police headquarters. Mr. Shankwitz was supposed to greet him in front next to his motorcycle.

“When I thought he was being brought out in a wheelchair, I was surprised when the door opened and a pair of sneakers showed up,” wrote Shankwitz in his memoir, Wish Man (2018). “Chris, an excited 7 year old boy who seemed so full of life it was hard to believe he was sick.”

Mr. Shankwitz showed Chris his motorcycle, and after he and the other officers gave him a badge, the department head made him an honorary officer. Chris was feeling well enough to go home that night, and the next day the officers brought him a custom-made uniform.

To become a motorcycle officer, Chris had to pass a driving test – which he took in his front yard on his small battery-powered motorcycle. Mr. Shankwitz promised to bring him a special badge worn by motorcycle police officers; He also called NBC, the network that broadcast “CHiPs,” and asked the stars of the show, Erik Estrada and Larry Wilcox, to sign a photo.

The next day Chris was back in the hospital and by the time Mr. Shankwitz arrived with the badge and picture, he had fallen into a mild coma. Chris had hung his uniform on the bed and when Mr. Shankwitz was putting the badge on his shirt, the boy woke up.

“Am I now an official motorcycle cop?” Asked Chris.

“You are sure,” replied Mr. Shankwitz.

Chris died later that day. Mr. Shankwitz and a colleague attended his funeral in southern Illinois and borrowed a pair of Illinois Highway Patrol motorcycles to accompany the hearse.

On the flight home, Mr. Shankwitz tried to process everything that had happened. He realized that what the department had done for Chris, he and his friends could do for other children.

Before he landed, he had devised a plan for the Make-a-Wish Foundation, which started just months later. Today the organization has 64 chapters in the US and 36 internationally that have “wishes” granted – from “eating in a restaurant” to “meeting the Pope” – to more than 500,000 seriously ill children.

Frank Earle Shankwitz was born in Chicago on March 8, 1943. His father, Frank Paul Shankwitz, was a salesman at Montgomery Ward. His mother, Lorraine Geraldine (Mathews) Shankwitz, was a waitress.

His parents split when he was 2 years old and fiercely fought for custody – his mother kidnapped him several times just to reach an uncomfortable deal with his father. When Frank was 10 years old, she took him to Arizona, where they lived in a trailer in the town of Seligman, which was close enough to the Nevada border that Mr. Shankwitz remembered seeing the glow from atomic bomb tests.

Mr. Shankwitz joined the Air Force immediately after high school and served five years as a military policeman, mainly on bomber bases in England. He left the service in 1965 and moved to Phoenix, where he worked for Motorola and enrolled in night classes at a local community college.

Though he was rapidly building a clerical career – in 1970 he had a wife, two children, and a mortgage and a college degree and a number of promotions – he became troubled with office life. Some of his high school friends had joined the Arizona Highway Patrol, and it wasn’t long before he applied. He was recorded in 1972; In 1975 he became part of an elite motorcycle unit that was supposed to patrol the entire state.

In 1978, Mr. Shankwitz was chasing a drunk driver when another drunk driver blinded him. His partner pronounced him dead, but an off duty nurse performed CPR and resuscitated him. It took him over a year to recover, and shortly after returning to duty, he met Chris Greicius.

Mr. Shankwitz and five other people founded the Make-a-Wish Foundation in 1980, a few months after Chris’ funeral. It grew quickly: within a few years it had become a national organization with state chapters open almost monthly.

In addition to his wife, two daughters, Christine Chester and Denise Partlow survive; three grandchildren; and two great-grandchildren. His first marriage to Sue Darrah ended in divorce.

Mr. Shankwitz never took a salary from Make-a-Wish and remained an active soldier on active duty until 1996; He later worked for the State Department of Motor Vehicles. He received the President’s Call to Service Award twice and was the subject of the 2019 biopic “Wish Man” with Andrew Steel as Mr. Shankwitz.

Mr. Shankwitz resigned as President of the Foundation in 1984. For decades, however, he remained the most visible ambassador and traveled the country to discuss chapters and to meet with “intended children”.

“I wake up every day passionate about making a difference in their life,” he wrote in his memoir. “It was once enough for me to be a father, a cowboy, and a patrolman. But my goal has changed. “

Categories
Health

Biden Covid response workforce holds briefing after J&J requests FDA OK for vaccine

[The stream is slated to start at 11 a.m. ET. Please refresh the page if you do not see a player above at that time.]

President Joe Biden’s Covid-19 Response Team will hold a briefing Friday on the coronavirus pandemic that left at least 455,875 Americans dead.

The briefing comes one day after Johnson & Johnson asked the Food and Drug Administration to approve the unique Covid-19 vaccine for use in the United States. The FDA has scheduled a meeting of its Advisory Committee on Vaccines and Related Biological Products in February 26 to discuss the vaccine, which could be distributed in the US as early as this month.

Federal and state officials are eagerly awaiting approval of J & J’s vaccine.Unlike Pfizer and Moderna’s vaccines, which require two doses three to four weeks apart, J & J’s drugs only require one dose , which makes logistics easier for healthcare providers.

Read CNBC’s live updates for the latest news on the Covid-19 outbreak.

Categories
Health

In Afghanistan, a Booming Kidney Commerce Preys on the Poor

HERAT, Afghanistan – In the midst of the hustle and bustle of beggars and patients outside the crowded hospital, there are sellers and buyers looking at each other suspiciously: the poor looking for money for their vital organs, and the seriously ill or their surrogate mothers looking for something to buy.

The illegal kidney business is booming in the western city of Herat, fueled by sprawling slums, poverty and endless war in the surrounding country, an entrepreneurial hospital bidding as the country’s first kidney transplant center, and officials and doctors turning a blind eye to organ trafficking.

In Afghanistan, as in most countries, the sale and purchase of organs is illegal, as is the implantation of purchased organs by doctors. However, the practice remains a worldwide problem, particularly with respect to the kidneys, as most donors can live with just one.

“These people need the money,” said Ahmed Zain Faqiri, a teacher who is looking for a kidney for his seriously ill father in front of Loqman Hakim Hospital. He was eyed uncomfortably by a young farmer, Haleem Ahmad, 21, who had heard about the kidney market and wanted to sell after his harvest failed.

The consequences will be dire for him. For the impoverished kidney vendors recovering in cold, unlit Herat apartments with peeling paint and concrete floors that have been temporarily freed from debt but are too weak to work, in pain and unable to afford medication, the deal is a portal for new misery. In one such apartment, half a sack of flour and a modest container of rice were the only food for a family with eight children last week.

Transplants are big business for Loqman Hakim Hospital. Officials boast more than 1,000 kidney transplants in five years, involving patients from across Afghanistan and the global Afghan diaspora. It offers them bargain deals at one-twentieth the cost of such procedures in the United States in a city with a seemingly endless supply of fresh organs.

When asked if the hospital made good money from the operations, Masood Ghafoori, a senior finance manager, said, “You could say that.”

The hospital takes care of the removal, transplant, and initial recovery for both patients without asking questions. Sellers say their hospital fees will be covered by the buyers and after a few days at the recovery center they will be sent home.

How the organ recipient gets the donor to agree to the procedure is not the hospital’s concern, the doctors say.

“It’s none of our business,” said Dr. Farid Ahmad Ejaz, a hospital doctor whose business card reads “Founder of Kidney Transplant in Afghanistan”.

Dr. Ejaz initially claimed that more than a dozen impoverished Herat residents lied when they told The Times that they had sold their kidneys for cash. He later admitted that “maybe” wasn’t the case. Interviews with other health officials here followed the same arc: initial denials, followed by reluctant appreciation.

“Everything has value in Afghanistan except human life,” said Dr. Mahdi Hadid, member of the Herat Provincial Council.

According to the United Nations, reports of organ sales in India date back to the 1980s, and today the practice accounts for around 10 percent of all global transplants. Iran, less than 80 miles from Herat, is the only country where kidney sales are not illegal as long as the parties are Iranian.

“There is always a gap between international guidelines and what governments do in practice,” said Asif Efrat, a faculty member at the Herzliya Interdisciplinary Center, a university in Israel, pointing out that Afghanistan compares to the countries in which it is located Organ trafficking is taking place, a new player is most productive: China, Pakistan and the Philippines. “The current international consensus is on the ban side, but governments have incentives not to follow it,” he said.

The moral scruples that keep business underground elsewhere are barely noticeable in Herat. Dr. Ejaz and health officials point out the hard logic of poverty. “The people in Afghanistan sell their sons and daughters for money. How does that compare to selling kidneys? “He asked. “We have to do this because someone is dying.”

Dr. Ejaz seemed unimpressed when he was shown the business card of a kidney broker: “In Afghanistan there are business cards with which people can murder others.”

On the fourth floor of the hospital, three in four recovering patients said they had bought their kidneys.

“I’m fine now,” said Gulabuddin, a 36-year-old imam, a kidney recipient from Kabul. “No pain at all.” He said he paid about $ 3,500 for his kidney that he bought from a “total stranger” with a $ 80 commission to the agent. He did a good deal: kidneys can cost up to $ 4,500.

“If there is approval, Islam has no problem with it,” said Gulabuddin.

Dr. Herat Province Public Health Director Abdul Hakim Tamanna acknowledged the rise of the kidney black market in Afghanistan but said there was little the government could do.

“Unfortunately, this is common in poor countries,” he said. “There is a lack of the rule of law and a lack of regulation related to this process.”

According to the World Bank, the poverty rate in Afghanistan is set to reach over 70 percent by 2020 and the country remains largely dependent on foreign aid. Domestic revenue only finances around half of the state budget. Without a substantial public safety net, healthcare is just another opportunity to take advantage of the most vulnerable people in the country.

Mir Gul Ataye, 28, regrets every second of his decision to sell his kidney deep in the maze of sandy streets in Herat’s slums. As a construction worker who made up to $ 5 a day prior to his surgery last November, he can now lift no more than 10 pounds, and hardly can.

“I am in pain and weak,” he said. “I’ve been sick and can’t control my piss.” Four children huddled in front of him on the concrete floor in the bare, unlit room. He said he supported a total of 13 family members and had around $ 4,000 in debt.

“It was difficult, but I had no choice. Nobody wants to give any part of their body to someone else, ”he said. “It was very embarrassing for me.”

Mr. Ataye received $ 3,800 for his kidney. That was almost three months ago. He’s still in debt and can’t pay his rent or electricity bill.

He said he felt “sadness, despair, anger and loneliness”. One night he was in such severe pain that he hit his head against the wall and fractured his skull.

Others around Herat gave similar reasons for selling a kidney: outstanding debts, sick parents, a marriage that would otherwise have been unaffordable.

“My father would have died if we hadn’t sold,” said Jamila Jamshidi, 25, who was sitting on the floor across from her brother Omid, 18, in a cold apartment on the outskirts of town. Both had sold their kidneys – she five years ago and he a year ago – and both were weak and in pain.

Mohammed Zaman, a tribal elder in a white turban, spoke of the irresistible attraction of Loqman Hakim’s kidney operation in a mud-walled camp just outside Herat, a vortex of sun, wind and dust filled with war refugees from other provinces. More than 20 from his village who have now been evicted from their homes had sold their kidneys.

“My people are hungry. We have no land. We can’t be shopkeepers. We don’t have any money, ”he said. “I can’t stop it.”

In a local restaurant, five brothers talked about being driven from their land in Badghis province by constant attacks by the Taliban. In Herat everyone had sold their kidneys. The youngest was 18, the oldest 32 years old.

“We had no choice,” said Abdul Samir, one of the brothers. “We had to sell. Otherwise we wouldn’t have sold a fingernail. “

Asad Timory and Kiana Hayeri contributed to the coverage.

Categories
Health

New York Gov. Cuomo, New Jersey Gov. Murphy maintain joint press briefing on Covid

[The stream is slated to start at 11:30 a.m. ET. Please refresh the page if you do not see a player above at that time.]

New York Governor Andrew Cuomo and New Jersey Governor Phil Murphy will hold a joint press conference on Friday on the coronavirus pandemic as both states gradually reopen their economies amid falling cases.

Both Cuomo and Murphy have taken steps over the past week to reopen more businesses in their states as they continue to introduce doses of Covid-19 vaccines. Last week, Cuomo said New York restaurants could reopen their limited capacity indoor eateries from February 14th.

Cuomo also said the state will take steps to allow some venues to reopen for wedding ceremonies from mid-March.

Meanwhile, Murphy announced on Wednesday that New Jersey restaurants could expand their indoor dining options from 25% to 35%. The state will also allow indoor gatherings for events such as weddings and funerals, as well as indoor venues with a 35% capacity or a limit of 150 people, he said.

New Jersey reports a weekly average of 3,973 Covid-19 cases per day, while New York reports an average of 9,722 cases per day, a decrease of more than 20% from the last one, according to a CNBC analysis of the compiled data for both states Week means from Johns Hopkins University.

Read CNBC’s live updates for the latest news on the Covid-19 outbreak.

Categories
Health

Immediately the Man Couldn’t See. Was His Chest Ache Related?

Amazed at the detailed pictures in front of him, the man asked if the clots could be removed. They couldn’t, Wang told him; What has been done has been done. But it was important to find out where these clots came from, otherwise it could happen again. Blood clots like this usually come from either the heart or the arteries that run from the heart to the brain and eye. The CT done in the hospital showed his carotid artery. No clots there. You would have to look into the heart. Wang added that up to 40 percent of strokes fail to find the source of the clot.

The most effective way to see the heart in action is to have an echocardiogram, Wang told the man. Most of the time the echo is normal. However, when something does come up, it is often important information.

A second stroke is most likely within a few days of the first. That patient was still in that window. Wang sent the patient to the emergency room at Yale New Haven Hospital and sent a message to the doctor on duty. It seemed clear to him that this was indeed some kind of emergency.

Joshua Hyman was a fourth year medical student just starting an ultrasound elective in the emergency room. The attending physician Dr. Karen Jubanyik suggested seeing this new patient who was there for an Echo. Jubanyik gave the student a brief overview of the case. Hyman introduced himself to the patient, then asked if it was okay for him to look at his heart. It would not be the official response, Hyman told the patient, it was just a way for him, a student, to learn.

The patient agreed, and Hyman rolled the bulky machine into the tiny cubicle. He squirted gel on an ultrasound probe and placed it a few inches below the patient’s left collarbone, just behind the sternum, in the space between the third and fourth ribs. He was still learning this technology, but he loved how it can give you information about what is going on in a patient’s body faster and sometimes better than anything else. When the probe is in this position, you can usually see the light gray muscles of the two chambers on the left side of the heart pressing around a dark black center that is the blood. This is the best way to see the business side of the heart. where blood from the lungs is injected into the bloodstream.

What he saw instead took his breath away. In the middle of the dark pools of blood moved a huge bright ball that raced back and forth across the screen with every heartbeat. What was that? Hyman froze the picture and took a measurement. A normal heart is about the size of a fist. This hitting circle was the size of a kiwi fruit.

Categories
Health

NY will start providing photographs to folks with underlying well being circumstances this month

A health care worker gives a picture of Moderna COVID-19 to a woman at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (COVID-19) pandemic in New York on January 29, 2021 Vaccine.

Facebook Facebook Logo Log in to Facebook to connect with Mike Segar Reuters

New York State plans to take unused Covid-19 vaccine doses from hospitals and distribute them to city and county health officials to distribute to people with underlying health conditions starting Feb.15, Governor Andrew Cuomo said on Friday.

The state has focused on vaccinating its health care workers and residents of long-term care facilities with its initial rations of Covid-19 shots. Now, hospitals have a week to use up their doses for staff before the state transfers the vials to local health departments for people with pre-existing health conditions that put them at high risk of serious illness, Cuomo said.

“Hospitals, you still have a week to get your hospital staff to accept the vaccine and then we will focus on the comorbidities,” Cuomo said at a press conference.

Cuomo didn’t immediately state what health conditions someone would need to get a vaccine, despite saying New York officials are working with the US Centers for Disease Control and Prevention to compile a “comorbidity list.” In January, the federal government, under the former Trump administration, proposed that states open up their vaccination eligibility to people 65 and over and to those with conditions like diabetes.

Later on Friday, the governor released a list of 15 underlying health conditions that would entitle a resident to a sting. Some of these conditions include cancer, heart failure, severe obesity, pregnancy, and diabetes, among others.

The Democratic governor added that the hospitals will continue to receive adequate care to vaccinate “who to do and who to plan and which workers to convince to take it”. All doses above that amount will be given to local health authorities, he said.

To date, New York has administered more than 1.7 million first vaccine doses from Pfizer-BioNTech and Moderna, as well as nearly 500,000 second vaccine doses, according to the Democratic governor. Around 7 million New Yorkers can currently be vaccinated.

Cuomo said the state has used almost all of its allotted doses and is now waiting for next week’s supply.

In mid-January, Cuomo expanded the pool of people eligible for vaccines in New York aged 65 and over, as well as those in certain key industries such as teachers, police and transit workers. However, some residents struggled to sign up for appointments in New York due to limited availability.

“We don’t have an offer that can reach everyone, we understand that,” said Cuomo. “So the prioritization is to reach those people who are most at risk or most important for this period.”

Categories
Health

The Coronavirus Is a Grasp of Mixing Its Genome, Worrying Scientists

In the past few weeks, scientists have been raising the alarm about new variants of the coronavirus that carry a handful of tiny mutations, some of which appear to make vaccines less effective.

But it’s not just these small genetic changes that are cause for concern. The novel coronavirus tends to mix up large chunks of its genome when making copies of itself. Unlike small mutations, which are like typos in sequence, a phenomenon called recombination is similar to a large copy-and-paste mistake, where the second half of a sentence is completely overwritten with a slightly different version.

A number of new studies suggest that recombination can allow the virus to transform itself in dangerous ways. In the long run, however, this biological machinery could provide a silver lining in helping researchers find drugs that will stop the virus.

“There’s no question that recombination is taking place,” said Nels Elde, an evolutionary geneticist at the University of Utah. “And in fact, it’s probably a little underrated and could even play a role in creating some of the new worrying variants.”

The coronavirus mutations that most people have heard of, like the one in the B.1.351 variant first discovered in South Africa, are changes in a single “letter” of the virus or RNA’s long genetic sequence. Because the virus has a robust system for proofreading its RNA code, these small mutations are relatively rare.

In contrast, recombination is widespread in coronaviruses.

Researchers at Vanderbilt University Medical Center, led by virologist Mark Denison, recently looked at how replication goes wrong in three coronaviruses, including SARS-CoV-2, which causes Covid. The team found all three viruses showed “extensive” recombination when replicated separately in the laboratory.

Scientists fear that recombination could combine different variants of the coronavirus into more dangerous versions in a person’s body. For example, variant B.1.1.7, first discovered in Great Britain, had more than a dozen mutations that appeared suddenly.

Dr. Elde said the recombination may have brought together mutations from different variants that may have arisen spontaneously within the same person over time or that co-infected someone at the same time. At the moment this idea is speculative: “It’s really hard to see these invisible scars from a recombination event.” And while it is possible to get infected with two variants at the same time, this is considered rare.

Katrina Lythgoe, an evolutionary epidemiologist at the Oxford Big Data Institute in the UK, is skeptical that co-infection is common. “But the new worrying variants have taught us that rare events can still have a big impact,” she added.

Recombination may also allow two different coronaviruses from the same taxonomic group to exchange some of their genes. To investigate this risk more closely, Dr. Elde and his colleagues tracked the genetic sequences of many different coronaviruses, including SARS-CoV-2 and some of its distant relatives that are known to infect pigs and cattle.

Using specially developed software, the scientists highlighted the places where the sequences of these viruses aligned and matched – and where they did not. The software suggested that in the last few centuries of virus evolution, many of the recombination events involved segments that made up the spike protein that helps the virus enter human cells. This is worrying, the scientists said, because it could be one way that one virus essentially infects another virus.

“Through this recombination, a virus that cannot infect humans could recombine with a virus like SARS-CoV-2 and take over the sequence for the tip and infect people,” said Stephen Goldstein, an evolutionary virologist who worked on the study.

Updated

Apr. 5, 2021, 8:13 p.m. ET

The results, which were posted online on Thursday but not yet published in a scientific journal, provided new evidence that related coronaviruses are quite promiscuous in terms of recombining with one another. There were also many sequences that appeared in the coronaviruses that seemed to come out of nowhere.

“In some cases, it almost looks like a sequence is coming from space, from coronaviruses that we don’t even know about,” said Dr. Elde. The recombination of coronaviruses across completely different groups has not been studied in detail, also because such experiments may have to be subject to a government review in the USA due to security risks.

Feng Gao, a virologist at Jinan University in Guangzhou, China, said that while the Utah researchers’ new software found unusual sequences in coronaviruses, it does not provide any iron evidence of recombination. It could just be that that’s how they evolved.

“Diversity, no matter how much, doesn’t mean recombination,” said Dr. Gao. “It could well be caused by tremendous diversification during virus development.”

Scientists have limited knowledge of whether new pandemic coronaviruses can arise through recombination, said Vincent Munster, a viral ecologist at the National Institute for Allergies and Infectious Diseases who has been studying coronaviruses for years.

Yet this evidence is growing. In a study published in July and officially published today, Dr. Munster and coworkers suggest that recombination is likely, as both SARS-CoV-2 and the virus behind the original SARS outbreak in 2003 resulted in a version of the spike protein that enables them to skillfully invade human cells. This spike protein binds to a specific entry point in human cells called ACE2. This paper calls for stronger coronavirus surveillance to see if there are others who are using ACE2 and therefore may pose similar threats to humans.

Some scientists are studying recombination machinery not only to ward off the next pandemic, but also to combat it.

For example, Dr. Vanderbilt’s Denison, in his recent study of the recombination of three coronaviruses, found that blocking an enzyme known as nsp14-ExoN in a mouse coronavirus caused a decrease in recombination events. This suggests that the enzyme is critical to the ability of coronaviruses to mix and match their RNA during replication.

Now, Dr. Denison and Sandra Weller, virologist at the University of Connecticut Medical School, asked whether this finding could treat people with Covid.

Certain antiviral drugs, like remdesivir, fight infection by acting as RNA bait that speeds up the viral replication process. But these drugs don’t work as well as some coronaviruses would have hoped. One theory is that the enzyme nsp14-ExoN removes the errors caused by these drugs and thus saves the virus.

Dr. Denison and Dr. Among other things, Weller are looking for drugs that block the activity of nsp14-ExoN and allow remdesivir and other antiviral agents to work more effectively. Dr. Weller compares this approach to cocktail therapies for HIV, which combine molecules that act on different aspects of virus replication. “We need combination therapy for coronavirus,” she said.

Dr. Weller notes that coronaviruses share nsp14-ExoN, so a drug that successfully suppresses it can work against more than just SARS-CoV-2. You and Dr. Denison are still in the early stages of drug discovery and are testing various molecules in cells.

Other scientists see potential in this approach not only to make drugs like remdesivir work better, but also to prevent the virus from correcting one of its replication errors.

“I think it’s a good idea,” said Dr. Goldstein, “because you would drive the virus into what is known as a ‘failure catastrophe’ – basically it would mutate so severely that it is fatal to the virus.”

Categories
Health

FDA approves new gadget worn in the course of the day to cut back loud night breathing and sleep apnea

The U.S. Food and Drug Administration on Friday approved a new device that can help prevent sleep apnea and snoring – and that doesn’t have to be worn at night.

People who snore – and their partners – have very few options in the market right now to alleviate their suffering. And a lot of what is available involves uncomfortable mouthguards or noisy C-Pap machines.

Approved on Friday, the eXciteOSA device is the first of its kind to be approved to treat sleep apnea and snoring by improving tongue muscle function by electrically stimulating the tongue through a mouthpiece worn for 20 minutes a day. It helps retrain the tongue to prevent it from collapsing backwards and blocking airflow while you sleep.

Obstructive sleep apnea is widespread and occurs when the upper airway becomes repeatedly blocked during sleep, reducing or completely blocking airflow. If left untreated, OSA can lead to serious complications such as glaucoma, heart attack, diabetes, cancer, and cognitive and behavioral disorders.

“Obstructive sleep apnea not only affects the quality of sleep, it can also have other serious health effects if left untreated. Today’s approval provides a new option for thousands of people with snoring or mild sleep apnea,” said Dr. Malvina Eydelman, director of the Ophthalmic, Anesthetic, Respiratory, ENT, and Dental Devices Bureau at the FDA’s Center for Equipment and Radiological Health.

The eXciteOSA mouthpiece has four electrodes, two above the tongue and two under the tongue. It provides electrical muscle stimulation in sessions that consist of a series of electrical impulses with periods of rest in between. It is used once a day for 20 minutes while you are awake, for 6 weeks, and then once a week thereafter.

The agency said the device reduced loud snoring by 20% in 87 of the 115 patients studied. Of the patients who all snored, 48 also had mild sleep apnea.

The most common side effects observed were excessive salivation, tongue or tooth discomfort, tongue tingling, tenderness to filling, metallic taste, gagging, and tight jaw.

The FDA has granted Signifier Medical Technologies marketing authorization.